1.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 2000.00, NCI-2009-01593, R01CA114218, FHCRC-2000.00, 8357, FHCRC-IR-6259, NCT00669669
|
2.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Over 18 Sponsor: NCI, Other Protocol IDs: CASE3405, P30CA043703, R21CA115057, CASE-CWRU-3405, 7080, NCT00961220
|